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ABSTRACT
Objective: The study aims at formulation and characterization of floating hydrogel beads of cefdinir for improving its bioavailability.
Methods: Cefdinir is broad-spectrum, oral, third-generation cephalosporin antimicrobial agent active against Gram-positive and Gram-negative 
bacteria. The floating hydrogel beads of cefdinir were formulated with polymers such as sodium alginate and sodium carboxymethyl cellulose by 
emulsion gelation technique using olive oil/castor oil. The beads were evaluated for surface morphology, bead size, entrapment efficiency, floating 
characteristics, in vitro swelling, in vitro drug release, and stability studies.
Conclusion: From the findings, it may be concluded that cefdinir-loaded floating beads were successfully prepared and proved to be useful for the 
better bioavailability and patient compliance for enhanced antimicrobial activity.
Keywords: Cefdinir, Emulsion gelation, Floating, Sodium carboxymethyl cellulose, Sodium alginate, Olive oil, Castor oil.
INTRODUCTION
Oral delivery of drugs is by far the most preferable route of drug delivery 
due to the ease of administration, patient compliance, and flexibility in 
formulation [1]. From immediate release to site-specific delivery, oral 
dosage forms have really progressed [2]. However, it is a well-accepted 
fact that it is difficult to predict the real in vivo time of release with 
solid, oral controlled release dosage forms. Thus, drug absorption in 
the gastrointestinal tract (GIT) may be very short and highly variable in 
certain circumstances [3].
One of the most feasible approaches for achieving a prolonged and 
predictable drug delivery profile in the GIT is to control the gastric 
residence time. Dosage forms with a prolonged gastroretentive dosage 
forms will provide us with new and important therapeutic options [4].
Cefdinir is a broad-spectrum, oral, third-generation cephalosporin 
antimicrobial agent active against Gram-positive and Gram-negative 
bacteria. It is used in treatment of acute chronic bronchitis, 
rhinosinusitis, pharyngitis, etc. Cefdinir is having half-life of 1.5 h with 
oral bioavailability 20–30%. Cefdinir is better absorbed from the upper 
part of the GIT [9].
Therefore, in the present study, an attempt will be made to design and 
evaluate GRDDS of cefdinir with a view to enhance its bioavailability, 
duration of action, and convenience of administration in the form of 
hydrogel beads as floating system leading to improved patient compliance.
MATERIALS AND METHODS
Methods
Standard calibration curve of cefdinir in 0.1 N HCL (pH 1.2) 
buffer solutions
Preparation of stock solution
Accurately weighed 10 mg of cefdinir was dissolved in small amount of 
0.1 N HCL (pH 1.2), and the volume was then made up to 100 ml with 
the same to obtain a concentration of 100 µg/ml.
Preparation of working standard solution
From the above solution, aliquots of 0.3, 0.6, 0.9, 1.2, 1.5, and 1.8 ml 
were transferred to a series of 10 ml volumetric flask and diluted up to 
the mark with 0.1 N HCL (pH 1.2) to give 3, 6, 9, 12, 15, and 18 µg/ml. 
Absorbance was measured spectrophotometrically at 287 nm against 
blank using Shimadzu Ultraviolet (UV) Spectrophotometer.
Method of floating bead formulation
Emulsion gelation technique
Solutions of sodium alginate and sodium CMC were prepared by stirring in 
distilled water. Cefdinir and olive oil/castor oil were added to the solution. 
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Results: On the basis of evaluation, all the beads show good swelling up to 12 h in 0.1 N hydrochloric acid. The swelling was followed by values 
in  order  of  vegetable  oil  >  mineral  oil  in  case  of  emulsion  gelation  method.  Scanning  electron  microscopy  study  shows  that  beads  were  spherical  in 
shape.  Comparing  all  the  formulations,  formulation  FB12  was  considered  as  optimized  formulation  which  shows  %  yield  94.06±0.11,  %  floating 
87.28±0.90, in vitro drug release 94.68, and also stable in stability studies.
Materials
Cefdinir  was  purchased  from  Rajesh  Chemicals,  Mumbai 
(India),  Sodium  alginate,  Sodium  carboxy  methyl  cellulose 
(CMC),  Calcium chloride,  Aluminum chloride,  Calcium Vegetable 
oil,  mineral  oil,  (SD  Fine  Chem  Ltd.,  Mumbai).  All  other  chemicals 
were of analytical grade.
Nowadays, alginate gel beads become post-acceptable vehicle for drug 
delivery since it is cost-effective, biodegradable, simple process 
[5].  Floating  is  the  most  acceptable  approach  of 
gastroretentive  drug  delivery  system  (GRDDS).  Floating  approach  is 
available  in  single  as  well  as  multiparticulate  forms  such  as  beads, 
microspheres, and pellets [6]. Beads spread out more uniformly in the 
GIT,  thus  avoiding  exposure  of  the  mucosa  locally  to  high 
concentration  of  drug  [7].  Beads  are  small,  solid,  and  free-flowing 
particulate carriers containing dispersed drug particles either in 
solution or crystalline form. Spherical beads of approximately 
2.5 mm in diameter [8].
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Each mixture with total volume of 100 ml (containing cefdinir 1 g and 
oil in two different concentrations 10 and 15%v/v) was stirred properly 
to prepare homogeneous mixtures. The mixture was extruded, using a 
20-gauge syringe needle into 200 ml of gently agitated calcium chloride 
(1%) or aluminum chloride (2%) solution at room temperature. The 
resulting beads were allowed to stand in the solution for 24 h before being 
separated and washed twice with 500 ml distilled water. The beads were 
dried at room temperature for 48 h and were stored in desiccators [10,11].
Characterization of floating beads
Scanning electron microscopy (SEM)
Morphological examination of the surface and internal structure of 
the dried calcium alginate beads was carried out using a SEM (JEOL 
JEM-1200 EX II, Japan) equipped with secondary electron detector at 
an accelerating voltage of 10 kV. The samples were coated with gold to a 
thickness of about 30 nm in a vacuum evaporator. The internal structure 
of beads was examined by cutting them with a steel blade [12].
Determination of bead diameter size
Particle size of the prepared beads was determined using an optical 
microscope fitted with the stage and an ocular micrometer. Twenty 
dried beads were measured for calculating the mean diameter of 
beads. The result is expressed as the mean diameter (mm)±standard 
deviation [13].
Drug content and entrapment efficiency
The drug content and entrapment efficiency of prepared beads were 
determined by the method of extraction of drug present in beads. The 
dried beads (100 mg) were taken and extracted in 100 mL of 0.1N HCl 
(pH 1.2) for 24 h. Then, the dispersion of beads was sonicated for 30 min 
and the solution was filtered through a 0.45 µm filter. The concentration 
of drug present in filtrate determined spectrophotometrically at 
287 nm (UV-2450, Shimadzu, Japan). Each determination was made 
in triplicate. The drug content and entrapment efficiency of prepared 
beads were determined by putting value in the following formula [14].
Calculated drug contentDrug content = ×100
Total amount of beads
Calculated drug contentEntrapment efficiency = ×100
Theoretical drug content
In vitro buoyancy
The time interval between the introduction of beads into the dissolution 
medium and its buoyancy to the top of dissolution medium was taken 
as floating lag time and floating time was observed visually. The floating 
abilities of the beads were determined using USP paddle apparatus 
(50 rpm, 37±0.2°C, 900 ml, 0.1 N HCl). 50 beads were placed in the 
medium; the time to float and duration of floating (floating time) were 
measured by visual observation. The percentage of floating pellets was 
calculated by the following equation: [15].
Floating beads (%) =
Number of floating beads at the measure time ×100
Initial number of beads
Swelling study
Beads were studied for swelling characteristics. Sample from 
drug-loaded beads was taken, weighed, and placed in wire basket. 
Beads were studied for swelling characteristics. Sample from 
Fig. 2: Scanning electron microscopy of cefdinir-loaded beads
FB1 FB2 FB3 FB4 FB5 FB6 FB7 FB8 FB9 FB10 FB11 FB12
Cefdinir 1 1 1 1 1 1 1 1 1 1 1 1
Sodium alginate 3 3 3 3 3 3 3 3 - - - -
Sodium CMC - - - - - - - - 2.5 2.5 2.5 2.5
Vegetable oil - - - - 10 10 15 15 - - 10 15
Mineral oil 10 10 15 15 - - - - 10 15 - -
CaCl2 1 - 1 - 1 - 1 - - - - -
AlCl2 - 2 - 2 - 2 - 2 2 2 2 2
CMC: Carboxymethyl cellulose
a b
Fig. 1: Calibration curve of cefdinir in 0.1 N HCl
Fig. 3: (a and b) Photographs of prepared cefdinir beads by 
emulsion gelation method
Table 1: Formulation batches of floating cefdinir floating beads
Ingredients Formulation code
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RESULTS AND DISCUSSION
The mean particle size of sodium alginate beads FB9–FB12 was 
between 1.58 mm and 1.99 mm. Sodium alginate beads were large 
when compared to sodium CMC due to molecular weight and viscosity. 
By increasing the oil concentration in the beads, an increase in size of 
the beads was observed.
Drug entrapment efficiency and floating study
The percentage yield of each batch was calculated on weight basis with 
respect to the weight of starting material. The percentage production 
yield of prepared beads was 81.98±0.32–96.10±0.08% for beads 
FB1–FB12 as shown in Table 4.
The mean drug entrapment efficiency of sodium alginate beads 
prepared by emulsion gelation technique of batch FB1–FB12 was 
between 58.14±1.87 and 84.50±0.33%. Hence, sodium alginate shows 
higher DEE than sodium CMC. Formulation FB1 shows higher DEE in 
both the methods 84.50±0.33%, suggesting that the emulsion gelation 
methods are effective for the entrapment of cefdinir.
Beads containing sufficient amount of oil FB1–FB12 demonstrated 
instantaneous floating ability and % floating was found to be 
62.25±1.40–94.60±1.05% (Table 5). Thus, floating ability was found to 
be directly related to the amount of oil entrapped in the polymer matrix. 
Furthermore, lower the density of oil, lesser amount of oil is required to 
float. The beads remained afloat throughout the study period 12 h and 
the beads continued to float until 24 h.









drug-loaded beads was taken, weighed, and placed in wire basket 
of USP dissolution apparatus II. The basket containing beads was 
placed in a beaker containing 900 ml of HCl solution (pH 1.2) 
maintained at 37±0.5°C. After 12 h, the beads were removed 
from their respective swelling media and weighed after drying 
the water on the surface of the beads using filter paper. Then, the 
swelling index was calculated as percentage using the following 
formula [16-19].
Final wt. of beads - Initial wt. of beadsSwelling index = ×100
Initial wt. of beads
Table 2: Calibration curve of cefdinir in 0.1 N HCl
Fig. 4: In vitro swelling data of cefdinir beads (FB1–FB4)
In vitro drug release studies
Release  studies  were  performed  in  triplicate  using  the  USP 
basket method at 100 rpm and 37±0.5°C in 1000 mL of 
test  medium  (i.e.,  SGF).  Approximately,  50  beads  were  used  for 
each experiment. The samples are withdrawn at  specific  time 
interval and assayed spectrophotometrically at the wavelength of 
maximum absorbance. The percentage of  the drug release 
is calculated with respect to the drug content of the beads.
 The  drug  content  is  expressed  as  the  percentage  of  drug 
encapsulated  in  a  unit  weight  of  beads.  The  experiments  are 
carried out in triplicate and the results were averaged [20-24].
Fig. 5: In vitro swelling data of cefdinir beads (FB5–FB8)
SEM
The surface morphology of prepared beads was studied by 
SEM. External and internal surfaces of beads formulation FB12 are
 shown  in  Fig.  2.  The  sodium  alginate  and  sodium  CMC  beads 
prepared with calcium chloride were spherical,  and the beads prepared 
with aluminum chloride were spherical with tail. External surface 
was smooth with slightly rougher surface/shrinkage which could be 
due to drying. In the drug-loaded beads , the internal surface is slightly 
sponge like which is due to the drug and rate controlling polymer are
 uniformly  dispersed  in  the  polymer  matrix.  The  internal  surface  of 
the oil-entrapped beads shows slightly sponge-like nature with little 
droplets  of  entrapped  oil  which  imparts  buoyancy  to  the  beads.  The 
surface  layer  of  all  beads  was  denser,  and  hence,  in  the  preparation 
process,  anionic  polymer  diffused  from  the  droplet  core  toward  the 
gelling  solution  (coagulation  medium)  to  form  more  heterogeneous 
structure.
Fig. 6: In vitro swelling data of cefdinir beads (FB9–FB12)
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In vitro swelling data of cefdinir beads
The swelling index of sodium alginate beads containing vegetable 
oil (olive oil) as floating agent (FB1, FB2, FB3, and FB4) was 238.04, 
240.7, 202.21, and 187.21, respectively, and for sodium alginate beads 
containing mineral oil as floating agent (FB5, FB6, FB7, and FB8) was 
293.27, 268.14, 240.17, and 251.77, respectively. The swelling index of 
sodium CMC beads (FB9, FB10, FB11, and FB12) was 288.14, 192.29, 
299.28, and 203.23, respectively. The swelling was followed by values 
in order of vegetable oil >mineral oil.
Formulation code Particle size (mm) (mean±SD) (n=20) Shape Color Oil leakage
FB1 1.94±0.08 Spherical Off-white Yes
FB2 2.02±0.02 Spherical disc Yellow Yes
FB3 2.10±0.05 Spherical Off-white Yes
FB4 1.98±0.07 Spherical disc Yellow Yes and high
FB5 2.08±0.04 Spherical with tail Off-white Intermediate
FB6 1.99±0.03 Spherical disc Off-white Yes
FB7 1.96±0.02 Spherical Off-white Yes
FB8 2.08±0.05 Spherical disc Off-white Intermediate
FB9 1.99±0.03 Spherical White Intermediate
FB10 1.67±0.06 Spherical Off-white Yes and high
FB11 1.97±0.05 Spherical White Intermediate
FB12 1.58±0.02 Spherical Off-white Yes and high
Table 4: Percentage yield and drug entrapment efficiency 
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Table 5: In vitro buoyancy study of cefdinir beads prepared by 









FB1 <1 >12 86.28±0.28
FB2 <1 >12 90.36±0.08
FB3 <1 >12 78.66±0.78
FB4 <1 >12 84.24±0.17
FB5 <1 >12 94.60±1.05
FB6 <1 >12 93.19±0.34
FB7 <1 >12 93.10±0.76
FB8 <1 >12 89.90±1.30
FB9 <2 >12 68.75±0.78
FB10 <2 >12 62.25±1.40
FB11 <1 >12 69.89±1.37
FB12 <2 >12 87.28±0.90
Time (h) Swelling index
FB5 FB6 FB7 FB8
1 49.8 73.71 51.11 39.67
2 85.32 98.26 69.41 69.245
3 179.96 172.2 133.5 99.72
4 237.02 218.41 171.5 143.2
5 247.15 229.32 199.27 201.93
6 256.74 250.41 222.7 223.55
7 279.52 267.4 237.12 239.98
8 293.27 268.14 240.17 251.77
Time (h) Swelling index
FB9 FB10 FB11 FB12
1 74.71 37.6 50.18 37.54
2 120.36 63.78 99.22 75.45
3 182.2 109.35 181.96 119.84
4 228.41 145.26 241.02 148.12
5 243.32 176.21 252.15 163.43
6 259.41 182.84 257.74 182.8
7 275.4 190.52 281.52 195.84
8 288.14 192.29 299.28 203.23
Time (h) Swelling index
FB1 FB2 FB3 FB4
1 49.01 40.67 36.25 34.65
2 73.34 66.45 52.84 64.71
3 132.5 97.22 117.82 127.35
4 169.95 153.2 146.12 144.26
5 200.02 199.93 161.43 174.21
6 225.47 219.55 179.48 179.84
7 236.21 231.98 196.54 186.75
8 238.04 240.7 202.21 187.21
Table 3: Particle size determination and visual analysis of cefdinir beads prepared by emulsion gelation technique (formulations FB1–FB12)
Table 7: In vitro swelling data of cefdinir beads (FB5–FB8)
Table 8: In vitro swelling data of cefdinir beads (FB9–FB12)
In vitro drug release data of cefdinir beads
The percentage cumulative drug release of sodium alginate beads prepared 
by emulsion gelation method using mineral oil (FB1–FB4) was 76.82, 80.37, 
81.81,  and  86.34%,  while  beads  prepared  by  emulsion  gelation 
method  using  vegetable  oil  (FB5–FB8)  was  64.61,  69.74,and  80.56%, 
respectively, at the end of 12 h and sodium CMC beads (FB9–FB12) show 
84.56,  92.58,  82.42,  and  94.68%,  respectively,  at  the  end  of  12  h. 
Hence,  increase the  concentration of  gas forming agent or oil 
concentration,  increase  the  percentage  cumulative  drug  release  was 
observed. Percentage cumulative drug release was followed by value in 
order of sodium alginate >sodium CMC. Furthermore, it was observed
 that polymers, sodium alginate and sodium CMC, show delayed release
 up to 12 h.
Table 6: In vitro swelling data of cefdinir beads (FB1–FB4)
The  stability  data  are  represented  in  Table  13,  and  the  stability 
study  was  performed  for  selected  formulation  FB12  for  3  months, 
suggesting  that  FB12  the  formulation  were  stable,  with  no 
physical change and also the floating ability,  DEE and cumulative 
% drug release, was not significant changed.
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CONCLUSION
Multiparticulate gastroretentive hydrogel beads of cefdinir were 
formulated with sodium alginate and sodium CMC by emulsion gelation 
method using olive oil/castor oil. The beads were evaluated for surface 
morphology, bead size, entrapment efficiency, floating characteristics, 
in vitro swelling, in vitro drug release, and stability studies. The prepared 
beads had a different size and the percentage entrapment efficiency 
of the drug. The SEM study shows that beads are spherical in shape. 
Comparing all the formulations, formulation FB12 was considered as 
optimized formulation which shows % yield 94.06±0.11, % floating 
87.28±0.90, in vitro drug release 94.68%, and also stable in stability 
Time (h) Cumulative % drug release
FB1 FB2 FB3 FB4
1 6.6 7.26 7.92 8.58
2 8.25 9.44 10.63 11.82
3 12.68 12.98 15.28 18.58
4 18.12 23.14 24.16 27.18
5 28.94 30.12 31.3 36.48
6 36.72 39.46 42.2 44.94
7 46.88 48.22 50.56 52.9
8 55.76 58.18 62.6 67.02
9 62.36 68.02 69.68 73.34
10 68.58 72.64 74.7 78.76
11 73.33 76.5 79.67 82.88
12 76.82 80.37 81.81 86.34
Time (h) Cumulative % drug release
FB5 FB6 FB7 FB8
1 5.9 6.26 6.62 6.98
2 9.92 10.98 11.04 12.1
3 11.74 13.8 15.86 17.92
4 20.28 22.82 27.36 31.9
5 29.56 32.12 36.68 43.24
6 33.12 38.23 43.34 48.45
7 51.94 50.02 58.1 60.18
8 56.86 59.23 65.6 67.97
9 64.61 69.74 74.87 80.56
10 69.25 74.14 79.03 83.92
11 76.51 77.5 82.49 88.48
12 77.28 82.08 86.88 91.68
Time (h) Cumulative % drug release
FB9 FB10 FB11 FB12
1 6.98 7.32 3.21 5.38
2 9.8 14.88 10.46 12.61
3 16.82 18.9 14.24 15.96
4 27.12 33.4 24.64 32.98
5 38.23 44.39 32.31 46.87
6 48.02 49.76 42.9 54.55
7 54.23 61.98 46.68 63.5
8 65.74 69.47 60.55 76.73
9 74.14 81.78 69.98 82.2
10 77.5 84.92 74.73 89.42
11 82.08 89.38 78.2 92.34
12 84.56 92.58 82.42 94.68
Formulation code Zero order (r2) First order (r2) Higuchi (r2) Peppas plot
(r2) n-value
FB1 0.9502 0.9160 0.9893 0.9948 1.2613
FB2 0.9336 0.7540 0.9956 0.9965 1.2138
FB3 0.9413 0.9970 0.9947 0.9929 1.2934
FB4 0.9141 0.8952 0.9891 0.9761 1.2934
FB5 0.9546 0.9527 0.9731 0.9778 1.1889
FB6 0.8655 0.9634 0.9783 0.9602 1.1802
FB7 0.9375 0.9928 0.9954 0.9936 1.1961
FB8 0.9420 0.9866 0.9909 0.9845 1.2754
FB9 0.9585 0.9810 0.9623 0.9623 1.3621
FB10 0.9750 0.9636 0.9262 0.9264 1.2364
FB11 0.9809 0.9612 0.9204 0.9204 1.1547
FB12 0.9665 0.9690 0.9280 0.9280 1.2067
Table 9: In vitro drug release data of cefdinir beads (FB1–FB4)
Table 10: In vitro drug release data of cefdinir beads (FB5–FB8)
Table 11: In vitro drug release data of cefdinir beads (FB9–FB12)
Fig. 7: In vitro drug release data of cefdinir beads (FB1–FB4)
Table 12: In vitro release data according to various release kinetic models
Fig. 8: In vitro drug release data of cefdinir beads (FB5–FB8)
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Table 13: Short-term stability study data of cefdinir-loaded beads (FB1 and FB9)
Sampling time (months) FB12
% floating (mean±SD) (n=3) % DEE (mean±SD) (n=3) Cumulative % drug release
0 87.28±0.90 81.91±0.42 94.68
1 86.05±0.31 81.42±0.21 95.69
2 87.91±0.22 81.24±0.17 94.45
3 87.66±0.14 80.13±0.08 93.23
SD: Standard deviation
studies. From the findings, it may be concluded that cefdinir-loaded 
floating beads were successfully prepared and proved to be useful for 
the prolonged gastric residence of the drug, better bioavailability, and 
patient compliance for enhanced antimicrobial activity.
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